Immediate Impact
1 by Nobel laureates 2 from Science/Nature 53 standout
Citing Papers
Possibilities and limitations of antisense oligonucleotide therapies for the treatment of monogenic disorders
2024 Standout
Polymeric Nanoparticles for Drug Delivery
2024 Standout
Works of James D. Peyton being referenced
Phase 1b/II study of cancer stemness inhibitor napabucasin in combination with FOLFIRI +/− bevacizumab (bev) in metastatic colorectal cancer (mCRC) patients (pts)
2017
A Randomized, Double-Blinded, Phase II Trial of Gemcitabine and Nab-Paclitaxel Plus Apatorsen or Placebo in Patients with Metastatic Pancreatic Cancer: The RAINIER Trial
2017
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| James D. Peyton | 199 | 145 | 172 | 27 | 359 | |
| Connie W. C. Hui | 123 | 151 | 157 | 21 | 381 | |
| József Lövey | 164 | 148 | 89 | 43 | 392 | |
| Shereen Rafee | 146 | 75 | 158 | 15 | 321 | |
| Satomi Yamamoto | 185 | 167 | 108 | 21 | 344 | |
| Chukwuemeka Ikpeazu | 181 | 139 | 116 | 23 | 340 | |
| N.G. Shah | 146 | 102 | 124 | 21 | 386 | |
| Mike Lau | 197 | 138 | 172 | 25 | 348 | |
| Patrick Chun | 242 | 100 | 139 | 19 | 359 | |
| Yanfen Feng | 191 | 84 | 127 | 39 | 411 | |
| Christoph Minichsdorfer | 130 | 112 | 195 | 33 | 406 |
All Works
Loading papers...